1-4 of 4
Saba Raya
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Salvage Regimens Lead to Better Response and Survival in Relapsed Refractory Classic Hodgkin Lymphoma after Autologous Stem Cell Transplant

Sanjal H Desai, Michael A Spinner, Kevin A. David, Veronika Bachanova, Gaurav Goyal, Jacques Azzi, Kathleen Dorritie, Vaishalee P. Kenkre, Cheryl Chang, Sally Arai, Brendon Fusco, Nuttavut Sumransub, Haris Hactic, Uroosa Ibrahim, Elyse Harris, Matthew J. Maurer, KC Rappazzo, Victor M. Orellana-Noia, Catherine S. Diefenbach, Saba Raya, Grzegorz S. Nowakowski, Ranjana Advani, Ivana N. Micallef
Journal: Blood
Blood (2021) 138 (Supplement 1): 878.
https://doi.org/10.1182/blood-2021-149880
Published: 2021
Journal Articles

Predictors of Relapse and Survival Following Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma

Marie Hu, Marcus P Watkins, Qing Cao, Saba Raya, David A. Russler-Germain, Veronika Bachanova, Todd A. Fehniger, Daniel J. Weisdorf
Journal: Blood
Blood (2021) 138 (Supplement 1): 1832.
https://doi.org/10.1182/blood-2021-146734
Published: 2021
Journal Articles

Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis

Allison M. Winter, MD, Wei Wei, MS, Emily C. Ayers, MD, Daniel J. Landsburg, MD, Saba Raya, MD, Brad S. Kahl, MD, Andrew Rogers, MD MS, Kami J. Maddocks, MD, Mohammad Khan, DO, MSBS, Adam S. Kittai, MD, Alexey Danilov, MD PhD, Chaitra S. Ujjani, MD, Ryan C. Lynch, MD, Loretta J. Nastoupil, MD MSc, Melody R. Becnel, MD, Luke Zurbriggen, MD, Vaishalee P. Kenkre, MD, Sheenu Sheela, MD, Nilanjan Ghosh, MD PhD, Boyu Hu, MD, Deborah M. Stephens, DO, Amy Ayers, MPH, Jonathon B. Cohen, MDMS, Brian T. Hill, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3982.
https://doi.org/10.1182/blood-2019-124783
Published: 2019
Journal Articles

Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure

Narendranath Epperla, MDMS, Luciano J. Costa, MD PhD, John L Vaughn, MD, Walter Hanel, MD PhD, Saba Raya, MD, Amanda F Cashen, MD, Rehan Sarmad, MD MBBS, Talha Badar, MD, Mehdi Hamadani, MD, Yang Liu, MD, Stefan K. Barta, MD MRCP, MS, Paolo Caimi, MD, Tarsheen K. Sethi, MD, Nishitha Reddy, MD, Madelyn Burkart, MD, Reem Karmali, MD, Celeste Bello, MD, Julio C. Chavez, MD, Shalin K. Kothari, MD, Francisco J. Hernandez-Ilizaliturri, MD, Hatcher J. Ballard, BS, Jakub Svoboda, MD, Lukas Emery, DO, Frederick Lansigan, MD, Martha Glenn, MD, Michael C. Churnetski, Jonathon B. Cohen, MDMS, Caryn Sorge, MD, Ana C. Xavier, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1554.
https://doi.org/10.1182/blood-2019-129199
Published: 2019